ICAM1 and endothelial dysfunction: Increased CRP and reactive oxygen species (ROS) could trigger endothelial dysfunction that can increase the levels of ICAM-1 and VCAM-1, leading to increased monocyte chemoattraction, binding to LDL-molecules and increased risk for cardiovascular disease [37].